Patient Decisions to Receive Secondary Pharmacogenomic Findings and Development of a Multidisciplinary Practice Model to Integrate Results Into Patient Care

Whole exome sequencing (WES) has the potential of identifying secondary findings that are predictive of poor pharmacotherapy outcomes. The purpose of this study was to investigate patients’ wishes regarding the reporting of secondary pharmacogenomic findings. WES results (n = 106 patients) were retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hicks, J. Kevin, Shealy, Amy, Schreiber, Allison, Coleridge, Marissa, Noss, Ryan, Natowicz, Marvin, Moran, Rocio, Moss, Timothy, Erwin, Angelika, Eng, Charis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759733/
https://www.ncbi.nlm.nih.gov/pubmed/28749586
http://dx.doi.org/10.1111/cts.12493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759733/
https://www.ncbi.nlm.nih.gov/pubmed/28749586
http://dx.doi.org/10.1111/cts.12493

Ejemplares similares